1-4 of 4
Qiuzhe Wei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bispecific CS1-BCMA CAR-T Cells Are Clinically Active in Relapsed or Refractory Multiple Myeloma: An Updated Clinical Study

Chenggong Li, Xindi Wang, Zhuolin Wu, Wenjing Luo, Yinqiang Zhang, Yun Kang, Jia Xu, Zhongpei Huang, Mengyi Du, Lu Tang, Jianghua Wu, Danying Liao, Haiming Kou, Cong Lu, Huiwen Jiang, Qiuzhe Wei, Sha Ke, Jing'e Zheng, Wei Xiong, Jun Deng, Yu Hu, Heng Mei
Journal: Blood
Blood (2022) 140 (Supplement 1): 4573–4574.
https://doi.org/10.1182/blood-2022-170686
Published: 2022
Journal Articles

Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies

Yinqiang Zhang, Chenggong Li, Huiwen Jiang, Wenjing Luo, Mengyi Du, Fen Zhou, Lu Tang, Jianghua Wu, Qiuzhe Wei, Cong Lu, Haiming Kou, Di Wu, Chang Alex H, Heng Mei, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4592–4594.
https://doi.org/10.1182/blood-2022-170819
Published: 2022
Journal Articles

Single-Cell Profiling Reveals Contribution of IFITM1 Expression to Severe CRS in CAR-T-Treated B-ALL

Mengyi Du, Chenggong Li, Fen Zhou, Wenjing Luo, Yinqiang Zhang, Lu Tang, Jianghua Wu, Huiwen Jiang, Qiuzhe Wei, Haiming Kou, Cong Lu, Chunrui Li, Heng Mei, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10321–10322.
https://doi.org/10.1182/blood-2022-168695
Published: 2022
Journal Articles

Autophagy Facilitates Cancer-Intrinsic Evasion of CAR T Cell-Mediated Cytotoxicity in B-Cell Malignancies

Heng Mei, Lu Tang, Huan Zhang, Fen Zhou, Mengyi Du, Jianghua Wu, Chenggong Li, Qiuzhe Wei, Wenjing Luo, Yinqiang Zhang, Xindi Wang, ZhaoZhao Chen, Jie Zhou, Zhuolin Wu, Zhongpei Huang, Yuxi Wen, Huiwen Jiang, Danying Liao, Haiming Kou, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 634–635.
https://doi.org/10.1182/blood-2022-168590
Published: 2022